Cormark Has Bearish Forecast for Cresco Labs FY2025 Earnings

Cresco Labs Inc. (OTCMKTS:CRLBF) – Analysts at Cormark reduced their FY2025 earnings estimates for shares of Cresco Labs in a research report issued to clients and investors on Monday, March 17th. Cormark analyst J. Pytlak now forecasts that the company will post earnings of ($0.07) per share for the year, down from their previous estimate of $0.03. Cormark currently has a “Moderate Buy” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Cormark also issued estimates for Cresco Labs’ FY2026 earnings at $0.01 EPS.

Separately, Atb Cap Markets downgraded shares of Cresco Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 9th. Two analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, Cresco Labs currently has an average rating of “Buy” and a consensus target price of $3.00.

Cresco Labs Stock Up 1.4 %

Shares of OTCMKTS CRLBF opened at $0.72 on Wednesday. The firm’s 50-day simple moving average is $0.87 and its 200 day simple moving average is $1.18. The company has a market cap of $349.02 million, a price-to-earnings ratio of -3.58 and a beta of 1.79. The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80. Cresco Labs has a 12-month low of $0.70 and a 12-month high of $2.60.

Cresco Labs (OTCMKTS:CRLBF) last issued its quarterly earnings results on Friday, March 14th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). The business had revenue of $176.00 million for the quarter, compared to the consensus estimate of $172.10 million. Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%.

Cresco Labs Company Profile

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.